Gene and Cell Therapy – News and Features

A ccording to a review article in Nature, scientists are making headway in exploring the potential future use of stem cells to treat heart disease.

Nanomedicine will cover the emerging scientific specialty born from nanotechnology.

Cell therapy manufacturing capacity increased in Mountain View, California.

Bioheart will receive funds from a grant awarded by the Biomedical Research and Commercialization Program of the State of Ohio.

Chemokine Therapeutics Corp. has announced that it has entered into an agreement with Fred Hutchinson Cancer Research Center to study the Company's hematological support compound, CTCE-0214.

The stem cells found in children’s primary teeth are a viable, ethical, and morally non-controversial alternative to the possibilities offered by embryonic stem cells.

The allowance of the patent underscores the Fibrin Microbead technology’s role in stem cell therapy.

As a provider of services in the biotechnology field, Cognate changed its name to better reflect its focus.

The Initiative ensures that Missouri patients will have access to any federally approved stem cell cures that are available to other Americans.

Study shows that a 'suicide' gene can be used to cut short rejection reactions following stem cell transplants.